Process Solutions experts collaborate with the world's leading drug developers to help bring drug therapies to patients. We are behind the scenes forging forward with our customers to help materialize life-enhancing and life-saving therapies.  

Our products and services are critical to the production of the top drugs for diseases such as breast cancer, lymphoma, diabetes, multiple sclerosis, migraines, Crohn's Disease, and pediatric brain cancer. Access to vaccines is accelerated by enabling local manufacturing. We innovate to bring technologies, such as CRISPR or ADCs (antibody drug conjugates), to the forefront.

We help best-position our customers for a smooth journey through the ever-changing regulatory landscape. Ensuring that drugs are safe, effective and consistent is a core competency.  At MilliporeSigma, we are with our customers at every step of the drug development process, shaping the possibilities for tomorrow.

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.

  • Andrew Bulpin Executive VP, Head of Process Solutions

    Andrew Bulpin is Head of the Process Solutions Business Unit.  In this role, he oversees R&D, Product Management and Marketing, the Services organization, as well as the Process Solutions Commercial teams.  Bulpin has held several roles since joining Millipore in 2006 as VP for the Upstream Processing business and later assumed leadership of the Services and Solutions business.

    Andrew holds a Ph.D. in Organic Chemistry from the Université de Caen, France, a MBA from the University of Strathclyde, Scotland, and a Bachelor degree from the University of Sussex, England.

  • Our Portfolio

    Process Solutions portfolio products and services are sold under three major brands: Millipore®, SAFC® or BioReliance®.



  • What we do

    Process Solutions helps our customers develop, make, purify, formulate and assure the quality of life-enhancing and life-saving drugs across our five franchises: bioprocessing, actives & formulations, end-to-end, gene editing & novel modalities, and testing services





Enter your email and tell us a bit about yourself, and we will keep you updated about latest company news and information about career opportunities that match your interests.

Already signed-up?